- Home
- CADL vs DBL Comparison
CADL vs DBL Comparison
Compare CADL & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- DBL
- Stock Information
- Founded
- CADL 1999
- DBL 2011
- Country
- CADL United States
- DBL United States
- Employees
- CADL N/A
- DBL N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- DBL
- Sector
- CADL Health Care
- DBL
- Exchange
- CADL Nasdaq
- DBL Nasdaq
- Market Cap
- CADL 265.7M
- DBL 291.3M
- IPO Year
- CADL 2021
- DBL N/A
- Fundamental
- Price
- CADL $5.63
- DBL $15.59
- Analyst Decision
- CADL Strong Buy
- DBL
- Analyst Count
- CADL 6
- DBL 0
- Target Price
- CADL $20.33
- DBL N/A
- AVG Volume (30 Days)
- CADL 718.8K
- DBL 61.0K
- Earning Date
- CADL 11-13-2025
- DBL 01-01-0001
- Dividend Yield
- CADL N/A
- DBL 8.67%
- EPS Growth
- CADL N/A
- DBL N/A
- EPS
- CADL N/A
- DBL N/A
- Revenue
- CADL N/A
- DBL N/A
- Revenue This Year
- CADL N/A
- DBL N/A
- Revenue Next Year
- CADL N/A
- DBL N/A
- P/E Ratio
- CADL N/A
- DBL N/A
- Revenue Growth
- CADL N/A
- DBL N/A
- 52 Week Low
- CADL $3.79
- DBL $13.75
- 52 Week High
- CADL $14.60
- DBL $15.70
- Technical
- Relative Strength Index (RSI)
- CADL 55.95
- DBL 57.38
- Support Level
- CADL $5.38
- DBL $15.43
- Resistance Level
- CADL $5.76
- DBL $15.64
- Average True Range (ATR)
- CADL 0.30
- DBL 0.12
- MACD
- CADL 0.08
- DBL -0.00
- Stochastic Oscillator
- CADL 86.46
- DBL 84.41
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.